drugset / Trial / NCT03973008

Adujvant CT+CRT vs Adujvant CT After D2 Resection for Locally Advanced Proximal Gastric Adenocarcinoma

NCT03973008

Phase 3 Unknown 408 enrolled Zhejiang Cancer Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

This study evaluates the addition of adjuvant chemoradiotherapy to adjuvant chemotherapy in the treatment of locally advanced proximal gastric adenocarcinoma after standard D2 radical resection.

Timeline

Start
2019-03-11
Primary completion
2024-02-29
Completion
2025-05-31

Drugs

EvaluationDrugModalityDoseRoute
Background Oxaliplatin Small molecule 130 mg/m2 Intravenous
Background Tegio Unknown 80 mg
Background Tegio Unknown 120 mg